{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T11:05:23Z","timestamp":1747825523612,"version":"3.27.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,20]]},"DOI":"10.7759\/cureus.71955","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T01:19:00Z","timestamp":1729473540000},"source":"Crossref","is-referenced-by-count":1,"title":["Influencers of Achievement of Remission and Low Disease Activity in Response to Disease-Modifying Antirheumatic Drugs (DMARDs) in Patients With Rheumatoid Arthritis"],"prefix":"10.7759","author":[{"given":"George O","family":"Oyoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Guantai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J","family":"Moots","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faith","family":"Okalebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George O","family":"Osanjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-018-0016-9","article-title":"Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies","volume":"6","author":"Guo Q","year":"2018","unstructured":"Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018, 6:15. 10.1038\/s41413-018-0016-9","journal-title":"Bone Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-022-02851-5","article-title":"Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: a machine learning approach using clinical trial data","volume":"24","author":"Duong SQ","year":"2022","unstructured":"Duong SQ, Crowson CS, Athreya A, et al.. Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: a machine learning approach using clinical trial data. Arthritis Res Ther. 2022, 24:162. 10.1186\/s13075-022-02851-5","journal-title":"Arthritis Res Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B","article-title":"Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins","volume":"43","author":"MacGregor AJ","year":"2000","unstructured":"MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, Silman AJ. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 2000, 43:30-7. 10.1002\/1529-0131(200001)43:1&lt;30::AID-ANR5&gt;3.0.CO;2-B","journal-title":"Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11206078","article-title":"Clinical factors and the outcome of treatment with methotrexate in rheumatoid arthritis: role of rheumatoid factor, erosive disease and high level of erythrocyte sedimentation rate","volume":"11","author":"Majorczyk E","year":"2022","unstructured":"Majorczyk E, Mazurek-Mochol M, Pawlik A, Ku\u015bnierczyk P. Clinical factors and the outcome of treatment with methotrexate in rheumatoid arthritis: role of rheumatoid factor, erosive disease and high level of erythrocyte sedimentation rate. J Clin Med. 2022, 11:10.3390\/jcm11206078","journal-title":"J Clin Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02746-5","article-title":"Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease","volume":"21","author":"Taylor PC","year":"2023","unstructured":"Taylor PC, Askari A, Choy E, Ehrenstein MR, Else S, Nisar MK. Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease. BMC Med. 2023, 21:55. 10.1186\/s12916-023-02746-5","journal-title":"BMC Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.22159","article-title":"Prediction of treatment response in rheumatoid arthritis patients using genome-wide SNP data","volume":"42","author":"Cherlin S","year":"2018","unstructured":"Cherlin S, Plant D, Taylor JC, et al.. Prediction of treatment response in rheumatoid arthritis patients using genome-wide SNP data. Genet Epidemiol. 2018, 42:754-71. 10.1002\/gepi.22159","journal-title":"Genet Epidemiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.063834","article-title":"Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan","volume":"9","author":"Matsui T","year":"2007","unstructured":"Matsui T, Kuga Y, Kaneko A, et al.. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann Rheum Dis. 2007, 9:1221-6. 10.1136\/ard.2006.063834","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151212","article-title":"Adherence and persistence with methotrexate in rheumatoid arthritis: a systematic review","volume":"43","author":"Curtis JR","year":"2016","unstructured":"Curtis JR, Bykerk VP, Aassi M, Schiff M. Adherence and persistence with methotrexate in rheumatoid arthritis: a systematic review. J Rheumatol. 2016, 43:1997-2009. 10.3899\/jrheum.151212","journal-title":"J Rheumatol"},{"key":"ref9","article-title":"Adherence to methotrexate therapy in rheumatoid arthritis","volume":"32","author":"Arshad N","year":"2016","unstructured":"Arshad N, Ahmad NM, Saeed MA, et al.. Adherence to methotrexate therapy in rheumatoid arthritis. Pak J Med Sci [Internet. 2016, 32:413-417.","journal-title":"Pak J Med Sci [Internet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S140457","article-title":"Medication adherence has an impact on disease activity in rheumatoid arthritis: a systematic review and meta-analysis","volume":"11","author":"Li L","year":"2017","unstructured":"Li L, Cui Y, Yin R, Chen S, Zhao Q, Chen H, Shen B. Medication adherence has an impact on disease activity in rheumatoid arthritis: a systematic review and meta-analysis. Patient Prefer Adherence. 2017, 11:1343-56. 10.2147\/PPA.S140457","journal-title":"Patient Prefer Adherence"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/ng1010-814","article-title":"Gene-environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritis","volume":"42","author":"van der Woude D","year":"2010","unstructured":"van der Woude D, Alemayehu WG, Verduijn W, de Vries RR, Houwing-Duistermaat JJ, Huizinga TW, Toes RE. Gene-environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritis. Nat Genet. 2010, 42:814-6; author reply 816. 10.1038\/ng1010-814","journal-title":"Nat Genet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06584-y","article-title":"Increased remission with fewer corticosteroids and more biologics in rheumatoid arthritis at 7-year follow-up in real-life conditions","volume":"12","author":"Larid G","year":"2022","unstructured":"Larid G, Vix J, Garlantezec R, Loppin E, Gervais E. Increased remission with fewer corticosteroids and more biologics in rheumatoid arthritis at 7-year follow-up in real-life conditions. Sci Rep. 2022, 12:2563. 10.1038\/s41598-022-06584-y","journal-title":"Sci Rep"},{"key":"ref13","article-title":"Addressing Social Determinants of Health: Examples of Successful Evidence-Based Strategies and Current Federal Efforts","author":"Whitman A","year":"2022","unstructured":"Whitman A, Lew ND, Chappel A, et al.. Addressing Social Determinants of Health: Examples of Successful Evidence-Based Strategies and Current Federal Efforts. Assistant Secretary for Planning and Evaluation, Washington DC; 2022."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-002058","article-title":"Association between social deprivation and disease activity in rheumatoid arthritis: a systematic literature review","volume":"8","author":"Dey M","year":"2022","unstructured":"Dey M, Busby A, Elwell H, et al.. Association between social deprivation and disease activity in rheumatoid arthritis: a systematic literature review. RMD Open. 2022, 8:10.1136\/rmdopen-2021-002058","journal-title":"RMD Open"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09451-5","article-title":"Associations between social determinants and the presence of chronic diseases: data from the osteoarthritis Initiative","volume":"20","author":"Vennu V","year":"2020","unstructured":"Vennu V, Abdulrahman TA, Alenazi AM, Bindawas SM. Associations between social determinants and the presence of chronic diseases: data from the osteoarthritis Initiative. BMC Public Health. 2020, 20:1323. 10.1186\/s12889-020-09451-5","journal-title":"BMC Public Health"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1515\/jom-2022-0162","article-title":"Social determinants of health in patients with arthritis: a cross-sectional analysis of the 2017 Behavioral Risk Factor Surveillance System","volume":"124","author":"Webb J","year":"2024","unstructured":"Webb J, Emmert R, Reddy A, Sajjadi NB, Greiner B, Bray N, Hartwell M. Social determinants of health in patients with arthritis: a cross-sectional analysis of the 2017 Behavioral Risk Factor Surveillance System. J Osteopath Med. 2024, 124:69-75. 10.1515\/jom-2022-0162","journal-title":"J Osteopath Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.19400","article-title":"Socioeconomic disparities in functional status in a national sample of patients with rheumatoid arthritis","volume":"4","author":"Izadi Z","year":"2021","unstructured":"Izadi Z, Li J, Evans M, et al.. Socioeconomic disparities in functional status in a national sample of patients with rheumatoid arthritis. JAMA Netw Open. 2021, 4:e2119400. 10.1001\/jamanetworkopen.2021.19400","journal-title":"JAMA Netw Open"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93394-3","article-title":"Effects of education, income, and occupation on prevalence and symptoms of knee osteoarthritis","volume":"11","author":"Lee JY","year":"2021","unstructured":"Lee JY, Han K, Park YG, Park SH. Effects of education, income, and occupation on prevalence and symptoms of knee osteoarthritis. Sci Rep. 2021, 11:13983. 10.1038\/s41598-021-93394-3","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06307-8","article-title":"Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis","volume":"41","author":"Khader Y","year":"2022","unstructured":"Khader Y, Beran A, Ghazaleh S, Lee-Smith W, Altorok N. Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis. Clin Rheumatol. 2022, 41:3615-27. 10.1007\/s10067-022-06307-8","journal-title":"Clin Rheumatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X17720366","article-title":"Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations","volume":"9","author":"Ajeganova S","year":"2017","unstructured":"Ajeganova S, Huizinga T. Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations. Ther Adv Musculoskelet Dis. 2017, 9:249-62. 10.1177\/1759720X17720366","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000382","article-title":"DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable","volume":"3","author":"Fleischmann RM","year":"2017","unstructured":"Fleischmann RM, van der Heijde D, Gardiner PV, Szumski A, Marshall L, Bananis E. DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable. RMD Open. 2017, 3:e000382. 10.1136\/rmdopen-2016-000382","journal-title":"RMD Open"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac114","article-title":"Mechanisms underlying DMARD inefficacy in difficult-to-treat rheumatoid arthritis: a narrative review with systematic literature search","volume":"61","author":"Roodenrijs NM","year":"2022","unstructured":"Roodenrijs NM, Welsing PM, van Roon J, et al.. Mechanisms underlying DMARD inefficacy in difficult-to-treat rheumatoid arthritis: a narrative review with systematic literature search. Rheumatology (Oxford). 2022, 61:3552-66. 10.1093\/rheumatology\/keac114","journal-title":"Rheumatology (Oxford)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.858817","article-title":"Editorial: drug survival: treatment of rheumatic diseases in the biologic era","volume":"9","author":"Di Sanzo L","year":"2022","unstructured":"Di Sanzo L, Scrivo R, Soriano ER, Citera G, Mysler E, Wei JC, R\u00edos MH. Editorial: drug survival: treatment of rheumatic diseases in the biologic era. Front Med (Lausanne). 2022, 9:858817. 10.3389\/fmed.2022.858817","journal-title":"Front Med (Lausanne)"},{"key":"ref24","article-title":"Patients Evaluate General\/Family Practice: The EUROPEP Instrument","author":"Grol R","year":"2000","unstructured":"Grol R, Wensing M. Patients Evaluate General\/Family Practice: The EUROPEP Instrument. EUROPEP Group, 2000."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11050639","article-title":"Patient satisfaction with healthcare services and the techniques used for its assessment: a systematic literature review and a bibliometric analysis","volume":"11","author":"Ferreira DC","year":"2023","unstructured":"Ferreira DC, Vieira I, Pedro MI, et al.. Patient satisfaction with healthcare services and the techniques used for its assessment: a systematic literature review and a bibliometric analysis. Healthcare (Basel). 2023, 11:639. 10.3390\/healthcare11050639","journal-title":"Healthcare (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/271489-influencers-of-achievement-of-remission-and-low-disease-activity-in-response-to-disease-modifying-antirheumatic-drugs-dmards-in-patients-with-rheumatoid-arthritis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T01:19:02Z","timestamp":1729473542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/271489-influencers-of-achievement-of-remission-and-low-disease-activity-in-response-to-disease-modifying-antirheumatic-drugs-dmards-in-patients-with-rheumatoid-arthritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,20]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.71955","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,20]]}}}